Gastric colonization and pneumonia in intubated critically ill patients receiving stress ulcer prophylaxis: a randomized, controlled trial

Crit Care Med. 1992 May;20(5):590-3. doi: 10.1097/00003246-199205000-00008.

Abstract

Objective: To study the effects of pharmacologically increasing gastric pH on gastric colonization and the development of pneumonia in intubated critically ill patients.

Design: Randomized, controlled trial.

Setting: Medical ICU in a university hospital.

Patients: Thirty-four tracheotomized patients with tetanus.

Interventions: Sixteen patients received iv ranitidine to increase gastric pH greater than 4 (ranitidine group), while 18 patients received no prophylaxis for upper gastrointestinal bleeding (control group).

Measurements and main results: Mean gastric pH was higher in the ranitidine group (median 4.7, range 3.6 to 6.1) than in the control group (median 2.1, range 1.2 to 4.9; p less than .05). Gastric colonization occurred in 15 (94%) of 16 patients who received ranitidine, 2 days (median; range 1 to 5) after intubation; gastric colonization also occurred in all control patients (median 4 days, range 1 to 9; p less than .05). Pneumonia occurred in 13 (81%) of 16 patients who received ranitidine, 3 days (median, range 1 to 5) after intubation and in nine (50%) of 18 control patients (p less than .01) 5 days after tracheal intubation (median, range 3 to 14; p less than .01). Prior gastric colonization by the pathogen that caused pneumonia was demonstrable in nine (56%) of 16 patients who received ranitidine vs. eight (44%) of 18 control patients (p greater than .05). The risk for developing pneumonia in the ranitidine-treated group was highest in the first 4 days after tracheal intubation. There was no difference in the frequency of upper gastrointestinal hemorrhage in the two groups.

Conclusions: Pharmacologically increasing gastric pH increases the risk for developing pneumonia in intubated critically ill patients. The pneumonia occurs earlier than in untreated control patients.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Critical Illness*
  • Gastric Juice / drug effects
  • Gram-Negative Bacterial Infections / epidemiology*
  • Gram-Negative Bacterial Infections / etiology
  • Gram-Negative Bacterial Infections / microbiology
  • Hospitals, University
  • Humans
  • Hydrogen-Ion Concentration
  • India / epidemiology
  • Intensive Care Units
  • Intubation, Intratracheal / adverse effects*
  • Length of Stay / statistics & numerical data
  • Male
  • Middle Aged
  • Peptic Ulcer / drug therapy*
  • Peptic Ulcer / etiology
  • Peptic Ulcer / prevention & control
  • Pneumonia / epidemiology*
  • Pneumonia / etiology
  • Pneumonia / microbiology
  • Prospective Studies
  • Ranitidine / administration & dosage
  • Ranitidine / adverse effects*
  • Ranitidine / therapeutic use
  • Risk Factors
  • Severity of Illness Index
  • Stomach Diseases / epidemiology*
  • Stomach Diseases / etiology
  • Stomach Diseases / microbiology
  • Stress, Psychological / complications*
  • Tetanus / complications
  • Tetanus / diagnosis
  • Tetanus / therapy*
  • Tracheostomy / adverse effects*

Substances

  • Ranitidine